読み込み中
HKSEHealthcareMedical - Care Facilities
最新データ
HK$9.61
+HK$0.12 · +1.26%
Hygeia Healthcare Holdings Co., Limited (6078.HK) is a prominent oncology healthcare provider primarily operating across the People's Republic of China. The company owns and manages a network of private, for-profit hospitals specializing in comprehensive cancer care. These facilities offer a broad spectrum of services, including diagnostic procedures such as tumor screening and genetic analysis, advanced therapeutic interventions like radiotherapy, surgery, chemotherapy, immunotherapy, and targeted treatments, alongside crucial supportive care including oncology rehabilitation, nutritional guidance, and hospice services. Beyond direct patient care, Hygeia also provides consulting expertise for radiotherapy centers and licenses its specialized SRT (Stereotactic Radiotherapy) equipment, offering ongoing maintenance and technical support for these systems. The company's operations extend to providing hospital and corporate management services, as well as supply chain solutions. By the end of 2021, Hygeia Healthcare had established a significant presence, operating or managing 12 oncology-focused hospitals spread across 9 cities in 7 provinces throughout mainland China. Established in 2009, the company maintains its headquarters in Shanghai, PRC.
最新データ
HK$9.61
+HK$0.12 · +1.26%
日中の時刻はHKTです。市場データは遅延する場合があります。
Hygeia Healthcare Holdings Co., Limited (6078.HK) is a prominent oncology healthcare provider primarily operating across the People's Republic of China. The company owns and manages a network of private, for-profit hospitals specializing in comprehensive cancer care. These facilities offer a broad spectrum of services, including diagnostic procedures such as tumor screening and genetic analysis, advanced therapeutic interventions like radiotherapy, surgery, chemotherapy, immunotherapy, and targeted treatments, alongside crucial supportive care including oncology rehabilitation, nutritional guidance, and hospice services. Beyond direct patient care, Hygeia also provides consulting expertise for radiotherapy centers and licenses its specialized SRT (Stereotactic Radiotherapy) equipment, offering ongoing maintenance and technical support for these systems. The company's operations extend to providing hospital and corporate management services, as well as supply chain solutions. By the end of 2021, Hygeia Healthcare had established a significant presence, operating or managing 12 oncology-focused hospitals spread across 9 cities in 7 provinces throughout mainland China. Established in 2009, the company maintains its headquarters in Shanghai, PRC.
日中レンジ
現在 HK$9.61
52週レンジ
現在 HK$9.61
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（CNY） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 40.09億 CNY | 44.46億 CNY | 40.77億 CNY | 31.96億 CNY | 23.15億 CNY |
| 売上原価 | 29.85億 CNY | 31.17億 CNY | 28.1億 CNY | 21.79億 CNY | 15.71億 CNY |
| 粗利益 | 10.23億 CNY | 13.29億 CNY | 12.67億 CNY | 10.17億 CNY | 7.45億 CNY |
| 研究開発 | 1004.6万 CNY | 1323.7万 CNY | — | — | — |
| 販売・一般管理 | 4.7億 CNY | 4.91億 CNY | 4.13億 CNY | 2.93億 CNY | 2.25億 CNY |
| 営業費用 | 6.3億 CNY | 5.08億 CNY | 3.78億 CNY | 3.5億 CNY | 1.51億 CNY |
| 受取利息 | 325.5万 CNY | 151.4万 CNY | 1015.3万 CNY | 1731.8万 CNY | 215.5万 CNY |
| 支払利息 | 6914.7万 CNY | 7184.2万 CNY | 4317万 CNY | 3488.1万 CNY | 2308.5万 CNY |
| 減価償却費と償却費 | 3.04億 CNY | 2.95億 CNY | 2.11億 CNY | 1.53億 CNY | 1.14億 CNY |
| 営業利益 | 3.93億 CNY | 8.21億 CNY | 8.89億 CNY | 6.67億 CNY | 5.94億 CNY |
| 純利益 | 1.65億 CNY | 5.98億 CNY | 6.83億 CNY | 4.77億 CNY | 4.41億 CNY |
会社概要が更新されました 2026年10月10日.
直近の発表実績
直近の発表実績
分割調整後の1株当たりの年間現金分配金。
HK$0.1636
2023年（通年）+13.6% 以来 2021
HK$0.1441
2,021
HK$0.1636
2,023
| 種別 | 配当落ち日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
配当 | 2023年6月30日 | HK$0.1636Irregular | 2023年7月3日 | 2023年7月27日 |
配当 | 2021年6月30日 | HK$0.1441Irregular | 2021年7月5日 | 2021年7月26日 |
配当落ち 2023年6月30日
HK$0.1636
Irregular
2023年7月3日基準 · 支払日 2023年7月27日
配当落ち 2021年6月30日
HK$0.1441
Irregular
2021年7月5日基準 · 支払日 2021年7月26日
この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Total International Stock ETFVXUS644.39万0.00%6657億 USD0.05%$84.82+0.86%
iShares Core MSCI Emerging Markets ETFIEMG601.1万0.00%1589.63億 USD0.09%$81.40+1.12%
Vanguard FTSE Emerging Markets ETFVWO594.69万0.00%1685億 USD0.06%$59.76+1.12%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS225.78万0.01%145億 USD0.06%$155.12+0.98%
iShares Core MSCI Total International Stock ETFIXUS138.43万0.00%582.06億 USD0.07%$94.99+0.90%
Dimensional - Emerging Markets Core Equity 2 ETFDFEM83.58万0.01%96.67億 USD0.39%$40.01+1.07%
State Street SPDR Portfolio Emerging Markets ETFSPEM63.31万0.00%175.23億 USD0.07%$52.21+1.32%
Avantis Emerging Markets Equity ETFAVEM50.71万—281.73億 USD0.33%$94.11+0.93%Vanguard Total International Stock ETFVXUSiShares Core MSCI Emerging Markets ETFIEMGVanguard FTSE Emerging Markets ETFVWOVanguard FTSE All-World ex-US Small-Cap ETFVSSiShares Core MSCI Total International Stock ETFIXUSDimensional - Emerging Markets Core Equity 2 ETFDFEMState Street SPDR Portfolio Emerging Markets ETFSPEMAvantis Emerging Markets Equity ETFAVEMAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
